68Ga-DOTATATE PET/CT Can Be an Alternative Imaging Method in Insulinoma Patients
dc.contributor.author | Tuzcu, Sadiye Altun | |
dc.contributor.author | Pekkolay, Zafer | |
dc.contributor.author | Kilinc, Faruk | |
dc.contributor.author | Tuzcu, Alpaslan Kemal | |
dc.date.accessioned | 2024-04-24T17:20:24Z | |
dc.date.available | 2024-04-24T17:20:24Z | |
dc.date.issued | 2017 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Insulinomas are the most common cause of hypoglycemia, resulting from endogenous hyperinsulinism. The diagnosis of insulinoma is established by demonstrating inappropriately high serum insulin concentrations during a spontaneous or induced episode of hypoglycemia. Most insulinomas are islet-cell tumors. They are often small (<2 cm), benign, and difficult to localize with current imaging techniques. Insulinomas can be detected using either noninvasive procedures (e.g., transabdominal ultrasonography, spiral CT, MRI, In-111-pentetreotide imaging, and F-18-L-dihydroxyphenylalanine PET) or invasive procedures (e.g., endoscopic ultrasonography) or a selective arterial calcium stimulation test with hepatic venous sampling. Methods: We performed Ga-68-DOTATATE PET/CT on 3 patients with insulinoma. Results: All patients' insulinomas were shown clearly with Ga-68-DOTATATE PET/CT. Conclusion: Ga-68-DOTATATE PET/CT imaging may be a useful noninvasive imaging technique to localize insulinomas preoperatively. | en_US |
dc.identifier.doi | 10.2967/jnmt.117.192708 | |
dc.identifier.endpage | 200 | en_US |
dc.identifier.issn | 0091-4916 | |
dc.identifier.issn | 1535-5675 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 28798227 | |
dc.identifier.scopus | 2-s2.0-85028871772 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 198 | en_US |
dc.identifier.uri | https://doi.org/10.2967/jnmt.117.192708 | |
dc.identifier.uri | https://hdl.handle.net/11468/19017 | |
dc.identifier.volume | 45 | en_US |
dc.identifier.wos | WOS:000416842000007 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Soc Nuclear Medicine Inc | en_US |
dc.relation.ispartof | Journal of Nuclear Medicine Technology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Ga-68-Dotatate Pet/Ct | en_US |
dc.subject | Insulinoma | en_US |
dc.subject | Neuroendocrine Tumor | en_US |
dc.title | 68Ga-DOTATATE PET/CT Can Be an Alternative Imaging Method in Insulinoma Patients | en_US |
dc.title | 68Ga-DOTATATE PET/CT Can Be an Alternative Imaging Method in Insulinoma Patients | |
dc.type | Article | en_US |